After losing nearly half its value from its 2021 highs, Pfizer stock (NYSE: PFE) now trades at about $25, presenting a potentially attractive value setup.

Barchart reports that Pfizer stock is showing unusual put option activity in yesterday's trading. Does that mean investors ...

Pfizer stock trades at a multi-year low with a 6.65% dividend yield. Click here for a full investment analysis of PFE stock.

Pfizer Inc. (NYSE:PFE) is one of the 10 Best Affordable Stocks Under $50 to Buy. On August 5, Morgan Stanley increased its ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported breakthrough survival data ...

Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $18.0 and $26.0 for Pfizer, spanning the last three months.

Eli Lilly & Company LLY and Pfizer PFE are both large-cap U.S. pharmaceutical giants with diversified drug portfolios and ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...